Outsourcing

Oct 01, 2008
BioPharm International
Despite the current regulatory uncertainty, pharmaceutical companies should move forward with planning for serialization and pedigree.
Oct 01, 2008
BioPharm International
The rapid growth of the pharmaceutical industry in India is yet to create significant changes in the Indian distribution system.
Aug 01, 2008
BioPharm International
What the Indian government is doing to make its biotech sector as strong as its IT sector.
Apr 01, 2008
BioPharm International
By BioPharm International Editors
There are several steps that you can take to ensure that you get the greatest benefit from consultants.
Jun 21, 2007
BioPharm International
By BioPharm International Editors
Intas Biopharmaceuticals Limited (IBPL, Gujarat, India, www.intasbiopharma.co.in) has become India's first dedicated biopharmaceutical company to receive certification from the European Agency for the Evaluation of Medicinal Products (EMEA, London, UK, www.emea.europa.eu) or an EU-GMP certification for its manufacturing facility at Ahmedabad, Gujarat.
Jun 21, 2007
BioPharm International
By BioPharm International Editors
The inaugural West Coast meeting for the Clinical Supplies Support Group (CSSG, www.jeiven.com/clinical_supplies_support_group.htm) was held in San Diego on June 8, 2007.
Oct 01, 2007
BioPharm International
There wasn't much of a contract services industry when BioPharm International began publishing 20 years ago. Today's big names in biomanufacturing, including Lonza, Boehringer-Ingelheim, and Avecia, had not yet entered the business.
Apr 02, 2008
BioPharm International
A decision-criteria matrix and cost models helped pinpoint the best distribution approach for the short- and long-term.
May 01, 2008
BioPharm International
By BioPharm International Editors
Recent problems with food and pharmaceutical ingredients sourced from China highlight a major disadvantage of our complex international supply chains for food and drug ingredients. A global supply chain offers more opportunities for accidental contamination as well as intentional adulteration and counterfeiting. Sticking to minimal requirements may not be enough.
Apr 02, 2007
BioPharm International
A tremendous amount of analytical testing is required to support a biopharmaceutical product from discovery, development, and clinical trials, through manufacturing and marketing. Numerous methods are used to fully characterize large molecules because of their complexity—characterizing them is significantly more difficult than it is for small molecules. Biopharmaceuticals are produced via living systems, i.e., E. coli, yeast, or mammalian cells, which require additional testing matrices.
native1_300x100
lorem ipsum